CoChat

Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review

Østergaard, L., Frandsen, Christian S., Madsbad, S. · 2016 · Expert Review of Clinical Pharmacology

The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.

Abstract

Over the last decade, the discovery of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) has increased the treatment options for patients with type 2 diabetes mellitus (T2DM). GLP-1 RAs mimic the effects of native GLP-1, which increases insulin secretion, inhibits glucagon secretion, increases satiety and slows gastric emptying. This review evaluates the phase III trials for all approved GLP-1 RAs and reports that all GLP-1 RAs decrease HbA1c, fasting plasma glucose, and lead to a reduction in body weight in the majority of trials. The most common adverse events are nausea and other gastrointestinal discomfort, while hypoglycaemia is rarely reported when GLP-1 RAs not are combined with sulfonylurea or insulin. Treatment options in the near future will include co-formulations of basal insulin and a GLP-1 RA.

Overview

Integrity signals

Registry

Crossref · 10.1586/17512433.2016.1121808

Cites

134 of 134 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 8

  1. American Diabetes Association, 2015, Diabetes Care, 38
  2. Lund A, 2014, Eur J Intern Med
  3. Robinson LE, 2013, BMJ Open, 3
  4. Mann KV, 2014, Diabetes Metab Syndr Obes Targets Ther, 7, 229
  5. Woodward HN, 2014, Patient Prefer Adherence, 8, 789
  6. Blair HA, 2015, Drugs
  7. 10.2337/dc09-0366 · DOI · Paper page
  8. Giorgino F, 2015, Diabetes Care

Cited by

See all 39

Metadata

Authors
Østergaard, L., Frandsen, C. S., & Madsbad, S.
Affiliations
University of Copenhagen (DK)
Corresponding author
Østergaard, L.
Venue
Expert Review of Clinical Pharmacology
Published
2016-01-08
Volume
9
Issue
2
Pages
241-265
ISSN
  • 1751-2433 (ISSN-L)
  • 1751-2441
OpenAlex
W2220690107
Cited by
38
References
134
Citations by year
2026: 5 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 3 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 7 · 2016: 5
FWCI
0.70
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Review of Clinical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
Keywords
GLP-1 receptor agonists, type 2 diabetes, glucagon-like peptide-1, insulin secretion, glucagon inhibition, satiety, gastric emptying, HbA1c reduction, fasting blood glucose, weight loss, nausea, hypoglycemia
MeSH terms
Glucagon-Like Peptide-1 Receptor, Insulin Secretion, Glucagon-Like Peptide-1 Receptor Agonists, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Glucagon, Humans, Hypoglycemic Agents, Insulin, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.